Predictive oncology announces abstract accepted for presentation at the 2024 american society of clinical oncology (asco) annual meeting

Pittsburgh, april 24, 2024 (globe newswire) -- predictive oncology inc. (nasdaq: poai), a leader in ai-driven drug discovery and biologics, today announced that an abstract has been accepted for presentation at the 2024 american society of clinical oncology (asco) annual meeting, which is being held may 31-june 4, 2024, in chicago, il.
POAI Ratings Summary
POAI Quant Ranking